August 2015 - New OncoMark CEO

Mr Desmond O'Leary joins OncoMark as Chief Executive

We are pleased to announce the appointment of Mr Desmond O Leary to the position of Chief Executive Officer of OncoMark. Mr O Leary is an experienced executive with over 20 years in the diagnostic industry.

He will lead OncoMark through the next phase of development to commercialise prognostics tests in the Oncology arena and penetrate a global market.

Mr. O'Leary has been involved in both start-ups and large international diagnostic companies, such as Biotrin International and Diasorin. He has extensive experience developing and launching new diagnostic tests and achieving EU and USFDA approvals.

 "I am delighted that Des has joined our team to help drive forward the commercialisation of OncoMarks' leading prognostics tests. Des has exactly the right experience and industry knowledge we need to achieve out commercialisation goals", says OncoMark founder and Chief Scientific Officer Prof. William Gallagher.